Osigraft
·
- Prescription status not stated
- Muscles, joints and bones
- Active substance
- Eptotermin alfa
- Used in
- Muscles, joints and bones
- Made by
- Olympus Biotech International Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of nonunion of tibia of at least 9 month duration, secondary to trauma, in skeletally mature patients, in cases where previous treatment with autograft has failed or use of autograft is unfeasible.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | Olympus Biotech International Limited |
|---|---|
| Active substance | Eptotermin alfa |
| Used in | Muscles, joints and bones |
| Classification | M05BC02 · Muscles, joints and bones |
| Authorised on | 2001-05-17 |
| Last updated by the regulator | 2016-07-27 |
| EMA product number | EMEA/H/C/000293 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.